Sign in to view content

Early Fluid-Free Status & Long-Term BCVA Outcomes With Anti-VEGF Treatment in nAMD: Post Hoc Analysis of Pooled Data From HAWK & HARRIER Studies

Chirag D. Jhaveri, MD, FASRS

Video
Published 2020

Related

Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients Treated With Intravitreal Aflibercept or Ranibizumab in the VIEW studies
Robert L. Avery, MD
On Demand Cases, Courses, and Papers
2017
Subfoveal Choroidal Thickness as a Prognostic Factor in Exudative Age related Macular Degeneration.
Jaya B. Kumar, MD, FASRS
On Demand Cases, Courses, and Papers
2017
Pharmacokinetic Profile of the Port Delivery System with Ranibizumab (PDS) in the Phase 3 Archway Trial
Peter A. Campochiaro, MD
Updates from the Field
2021

Category: AMD-Neovascular

See more